READ: ARW ON CGT
It’s unlikely we will need to burn nearly as much “midnight oil” as Moderna and the regulatory bodies did during the pandemic. However, I share Moderna's unique experiences because they’re a great reminder that the mRNA therapeutics industry is set to face a much different regulatory challenge moving forward.
Cell & Gene Therapy COGS: Progress & Pitfalls In Our Quest For Affordability
We regularly talk about “getting to know” our products. This can mean a lot of different things depending on the functional area in which we work. But as conversations about affordability and commercial sustainability increase pressure on manufacturing teams, I wanted to get Spink’s thoughts on how we can understand our products from a COGS standpoint and how this will continue to challenge us in the years ahead.
WATCH: ARW ON RNA
The Game Of RISK Meets mRNA | ARW On RNA Ep02
Hosted by Cell & Gene Collaborative's Director Anna Rose Welch, ARW on RNA puts a creative spin on the emerging mRNA + RNA therapeutics industry. Here, in Episode 2, Welch outlines how The Game of RISK can serve as a great example for the mRNA therapeutics industry in its long-term quest to standardize the mRNA drug product manufacturing paradigm.
Harry Potter Meets mRNA | ARW On RNA Ep01
Hosted by Cell & Gene Collaborative's Director Anna Rose Welch, ARW on RNA puts a creative spin on the emerging mRNA + RNA therapeutics industry. Here, in Episode 1, Welch draws a few connections between the magical world of Harry Potter and the challenging scientific work mRNA companies are doing today to explore and/or broaden mRNA's therapeutic potential in a variety of indications.
Introducing ARW On RNA!
Hosted by Cell & Gene Collaborative's Director Anna Rose Welch, ARW on RNA puts a creative spin on the emerging mRNA + RNA therapeutics industry. How can the game of RISK, Harry Potter, and Michelangelo's David bring clarity to the innerworkings of the mRNA + RNA therapeutics industry? Join us for a wild ride through pop culture and its potential to further our understanding of these therapeutics.
ABOUT CELL & GENE COLLABORATIVE
We are an editorial resource and virtual peer-group bringing together the best and brightest manufacturing minds in the advanced therapies industry. We cue the conversations and provide an off-the-beaten path forum for manufacturing professionals to meet their peers and learn from each other — and have a great time doing it.
Anna Rose Welch is the director of Cell & Gene Collaborative. In this role, she is forging close relationships with the leading voices and organizations in the cell and gene therapy manufacturing sphere. This includes establishing a peer group comprising Cell & Gene company manufacturing SMEs, conducting interviews and hosting interactive roundtables on the evolving manufacturing paradigm, and authoring thought leadership articles and blog posts via the Cell & Gene Collaborative blog.